BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36305215)

  • 21. A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
    Chohan K; Mittal N; McGillis L; Lopez-Hernandez L; Camacho E; Rachinsky M; Mina DS; Reid WD; Ryan CM; Champagne KA; Orchanian-Cheff A; Clarke H; Rozenberg D
    Chron Respir Dis; 2021; 18():14799731211025313. PubMed ID: 34291699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial of heavy shoulder strengthening exercise in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome and long-lasting shoulder complaints: study protocol for the Shoulder-MOBILEX study.
    Liaghat B; Skou ST; Søndergaard J; Boyle E; Søgaard K; Juul-Kristensen B
    Trials; 2020 Dec; 21(1):992. PubMed ID: 33261635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of complementary therapies for chronic pain management in patients with reported Ehlers-Danlos syndrome or hypermobility spectrum disorders.
    Demes JS; McNair B; Taylor MRG
    Am J Med Genet A; 2020 Nov; 182(11):2611-2623. PubMed ID: 32909698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
    Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
    Gensemer C; Burks R; Kautz S; Judge DP; Lavallee M; Norris RA
    Dev Dyn; 2021 Mar; 250(3):318-344. PubMed ID: 32629534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities.
    Fairweather D; Bruno KA; Darakjian AA; Bruce BK; Gehin JM; Kotha A; Jain A; Peng Z; Hodge DO; Rozen TD; Munipalli B; Rivera FA; Malavet PA; Knight DRT
    Front Med (Lausanne); 2023; 10():1096180. PubMed ID: 37181352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring pain mechanisms in hypermobile Ehlers-Danlos syndrome: A case-control study.
    De Wandele I; Colman M; Hermans L; Van Oosterwijck J; Meeus M; Rombaut L; Brusselmans G; Syx D; Calders P; Malfait F
    Eur J Pain; 2022 Jul; 26(6):1355-1367. PubMed ID: 35442549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.
    Miller AJ; Stiles LE; Sheehan T; Bascom R; Levy HP; Francomano CA; Arnold AC
    Auton Neurosci; 2020 Mar; 224():102637. PubMed ID: 31954224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
    DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
    J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermobile type Ehlers-Danlos syndrome associated with hypogammaglobulinemia and fibromyalgia: A case-based review on new classification, diagnosis, and multidisciplinary management.
    Zhang W; Windsor K; Jones R; Taunton DO
    Clin Case Rep; 2019 Apr; 7(4):680-685. PubMed ID: 30997063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The concomitant diagnosis of fibromyalgia and connective tissue disorders: A systematic review.
    Alsiri N; Alhadhoud M; Alkatefi T; Palmer S
    Semin Arthritis Rheum; 2023 Feb; 58():152127. PubMed ID: 36462303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorders in the context of childbearing: An international qualitative study.
    Pezaro DS; Pearce DG; Reinhold DE
    Midwifery; 2020 Sep; 88():102749. PubMed ID: 32535291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and quality of temporomandibular disorders, chronic pain and psychological distress in patients with classical and hypermobile Ehlers-Danlos syndrome: an exploratory study.
    Willich L; Bohner L; Köppe J; Jackowski J; Hanisch M; Oelerich O
    Orphanet J Rare Dis; 2023 Sep; 18(1):294. PubMed ID: 37726791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comprehensive Review: Chronic Pain Sequelae in the Presence of Ehlers-Danlos Syndrome.
    Basem JI; Lin T; Mehta ND
    Curr Pain Headache Rep; 2022 Dec; 26(12):871-876. PubMed ID: 36434419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anorectal manometry for the diagnosis of pelvic floor disorders in patients with hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome.
    Zhou W; Zikos TA; Halawi H; Sheth VR; Gurland B; Nguyen LA; Neshatian L
    BMC Gastroenterol; 2022 Dec; 22(1):538. PubMed ID: 36564719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the beliefs, needs, and expectations for genetic counseling of patients with hypermobile Ehlers-Danlos syndrome.
    Ahimaz P; Kramer T; Swaroop P; Mitchell M; Hernan R; Anyane-Yeboa K; Pereira EM
    Am J Med Genet A; 2022 Nov; 188(11):3172-3183. PubMed ID: 36209348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
    Brock I; Prendergast W; Maitland A
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of chronic pain in Ehlers-Danlos syndrome: Two case reports and a review of literature.
    Zhou Z; Rewari A; Shanthanna H
    Medicine (Baltimore); 2018 Nov; 97(45):e13115. PubMed ID: 30407326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gnathological and osteopathic treatments with digital evalua- tions before and after therapies: a case report of a patient with ehlers-danlos syndrome.
    Di Giacomo P; Cerignoli E; D'Ermes V; Ferrato G; Polimeni A; Di Paolo C
    Clin Ter; 2021 May; 172(3):179-185. PubMed ID: 33956032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.
    Engelbert RH; Juul-Kristensen B; Pacey V; de Wandele I; Smeenk S; Woinarosky N; Sabo S; Scheper MC; Russek L; Simmonds JV
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):158-167. PubMed ID: 28306230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.